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One of the most successful public health applications
of next-generation sequencing is whole-genome
sequencing of pathogens to not only detect and
characterize outbreaks, but also to inform outbreak
management. Using genomics, infection control teams
can now track, with extraordinarily high resolution, the
transmission events within outbreaks, opening up
possibilities for targeted interventions. These successes
are positioning the emerging field of genomic
epidemiology to replace traditional molecular
epidemiology, and increasing our ability to limit the
spread of multidrug-resistant organisms.power of previous methods. However, the introductionGenomic epidemiology for healthcare-associated
infections
Healthcare-associated infections (HAIs) are a significant
cause of morbidity and mortality in hospitalized patients
and represent a major economic burden for healthcare
systems. In the United Kingdom, it has been estimated
that as many as 300,000 HAIs occur annually at a cost
of over £1 billion per year, and that, at any given time,
one in every fifteen hospital patients has an HAI [1]. Evi-
dence suggests that approximately 20% of HAIs are pre-
ventable [2] and, indeed, HAI point prevalence - the
percentage of hospitalized patients with an HAI at any
point in time - is decreasing in the United Kingdom,
down to 6.4% in 2011 from a high of 9.2% in 1980. How-
ever, factors including breakdowns in infection preven-
tion and control practices, unrecognized transmission in
the community, and importation of new strains of
antimicrobial-resistant pathogens from endemic regions
of the world mean that hospitals are regularly seeing the* Correspondence: patrick.tang@bccdc.ca
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settings. While surveillance and screening, in combin-
ation with molecular genotyping, can indicate the pres-
ence of a nosocomial outbreak, conventional molecular
epidemiology methods lack sufficient resolution to reveal
the origins and transmission dynamics of these outbreaks -
information integral to implementing appropriate and
effective infection control strategies.
Over the past few decades, a series of molecular epi-
demiology methods, including pulsed field gel electrophor-
esis and multi-locus sequence typing, have been developed
to estimate phylogenetic relationships between bacterial
isolates - each one trying to improve upon the speed,
accuracy, reproducibility, ease of use or discriminatory
of next-generation genome sequencing technology has
trumped most of these iterative improvements by offering
the ultimate in discriminatory power at a relatively low
cost. It has the additional benefits of being able to predict
antimicrobial resistance phenotypes and identify virulence
factors. The potential of this new ‘genomic’ epidemiology
for the detection, characterization and management of
infectious disease outbreaks, as demonstrated by Pallen
and colleagues in this issue of Genome Medicine [3], is tre-
mendous. Genomic epidemiology has been instrumental
for resolving hospital outbreaks, sometimes disproving
previous assumptions regarding nosocomial pathogen
transmission. For example, in a recent study of Staphylo-
coccus aureus transmission in an intensive care unit (ICU),
whole-genome sequencing revealed new transmission
events that were missed, and disproved transmission
events that were falsely predicted by conventional
genotyping [4]. Another study using genomics to study
vancomycin-resistant enterococci (VRE) revealed that
de novo acquisition of vancomycin resistance in Entero-
coccus faecium is probably underappreciated in the hospital
environment and that VRE screening at admission may not
be sufficient to control VRE within hospitals [5].tral Ltd. The licensee has exclusive rights to distribute this article, in any
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ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Tang and Gardy Genome Medicine 2014, 6:104 Page 2 of 3
http://genomemedicine.com/content/6/11/104Recent examples of genomic epidemiology in real
time
Most genomic epidemiology studies to date have retro-
spectively analyzed outbreaks, and although this has
revealed important insights into pathogen transmission
dynamics, the challenge has been to apply genomic epi-
demiology to directly impact an ongoing outbreak. Only a
handful of nosocomial outbreak studies have been per-
formed in real time with the goal of reducing the duration
and impact of transmission, including important early
work in an outbreak of methicillin-resistant S. aureus
on a neonatal intensive care ward [6] and a carbapenem-
resistant Klebsiella pneumoniae outbreak that persisted
despite early infection control measures [7].
In 2010, Pallen and colleagues were the first to use
whole-genome sequencing to identify a person-to-person
transmission event in an infectious disease outbreak, se-
quencing six isolates of multi-drug resistant (MDR) Aci-
netobacter baumannii from a 2008 hospital cluster to
trace transmission between a military and a civilian pa-
tient [8]. Now, they report the results of a genomic in-
vestigation of a protracted MDR A. baumannii outbreak
involving a novel strain of the bacterium not previously
observed in hospitals in the United Kingdom or other
strain collections [9].
The outbreak began with the importation of the novel
MDR A. baumannii via a military patient, with early sec-
ondary cases - linked through conventional molecular
epidemiology techniques - occurring on the same ward.
At week 40 of what ultimately became an 80-week out-
break, the authors replaced traditional molecular epidemi-
ology methods with whole-genome sequencing, noting
that with the less than 1-week turnaround time they
achieved with genomics, they were able to more rapidly
rule in or rule out isolates as belonging to the outbreak.
Of the 102 clinical isolates successfully sequenced, a
threshold of less than or equal to 8 single nucleotide vari-
ants (SNVs) ruled in 74 genomes as belonging to a single
large outbreak, including 52 from individual patient iso-
lates and 10 from environmental sampling.
Phylogenetic analysis of the 74 genomes identified 32
distinct genotypes belonging to seven major clusters.
Using a Python script that factors in patient genotype,
the ward patients are housed in, and the date of their
first positive test, the authors refined the 273 possible
transmission events suggested by epidemiology alone to
the 57 supported by the genomic data. In this fashion,
they established the most parsimonious source of infec-
tion for all but 10 patients. The genomic epidemiology
suggested that early transmissions occurred through
ward-based contact but also through long-term environ-
mental contamination of specific wards, which prompted
improved ward decontamination procedures. The genom-
ics also implicated a specific operating theatre for burnspatients in several transmissions, leading the infection
control team to perform a deep clean of the theatre.
Despite the ward and theatre decontaminations, which
had initially appeared to halt the outbreak’s spread, an-
other series of cases occurred from week 70 onwards.
The genomic investigation linked the first of these to a
contaminated bed, prompting the development of a
cleaning protocol specific to this type of bed, with subse-
quent cases traced again to the burns theatre. Following
a second deep cleaning of the theatre, no further trans-
missions were observed and the outbreak was declared
over at week 80.
The real-time use of genomics to reveal transmissions
and target infection control interventions to the correct
place - be it a ward, operating theatre, or bed - is the
most notable aspect of this comprehensive and import-
ant work, clearly demonstrating the immediate impact
that genomics-informed interventions can have on stop-
ping transmission. It is also worth noting the authors’
use of a software script to develop a putative transmis-
sion network - automated approaches can make genomic
epidemiology more tractable for infection control teams
that may not have specific expertise in interpreting gen-
omic data through the lens of traditional epidemiological
relationships.
What the future holds
With this work, Pallen and colleagues make a convincing
case for the utility of whole-genome sequencing as an
integral part of infection control practice, demonstrating
that it can be done in a clinical setting in real time and
that it can lead to evidence-based and effective interven-
tions to stop even a large and protracted hospital
outbreak. Given continued advances in technology, such
as single-molecule sequencing [10] and bioinformatics
methods to resolve mixed infections [11], the accurate and
rapid response platform provided by next-generation se-
quencing will become a cornerstone of infection control.
We envision a near future in which hospital laboratories
are equipped with genome sequencing technology, en-
abling pathogen genomes to be derived from direct se-
quencing of clinical samples, with automated analysis
methods to predict drug resistance or to identify clus-
ters of related genomes suggestive of an outbreak. These
data will inform the hospital’s infection control pro-
gram, allowing for real-time evidence-based manage-
ment of outbreaks, and ultimately decreasing the
prevalence of HAIs.
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